[JOINT FILING AGREEMENT Rule 13d-1(k) under In accordance with the requirements of This agreement may be executed in any number of counterparts, each of which shall be deemed an original. EXECUTED this 14th day of February, 2019. Altaba Inc. Thomas J. McInerney Thomas J. McInerney Chief Executive Off]
[SCHEDULE 13G/A Amendment No. 14 Global Cord Blood Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 698659109 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) *]
[JOINT FILING AGREEMENT Rule 13d-1(k) under In accordance with the requirements of This agreement may be executed in any number of counterparts, each of which shall be deemed an original. EXECUTED this 14th day of February, 2019. Altaba Inc. Thomas J. McInerney Thomas J. McInerney Chief Executive Off]
[SCHEDULE 13G/A Amendment No. 14 Global Cord Blood Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 698659109 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) *]
[Joint Filing Agreement 13d-1(k) In accordance with Rule [Remainder of this page has been left intentionally blank.] 16 Sheng Chen Sheng Chen Fast Horse Technology Limited Sheng Chen Director Sunrise Corporate Holding Ltd. Sheng Chen Director Personal Group Limited Sheng Chen Director Beacon Capital ]
[Joint Filing Agreement 13d-1(k) In accordance with Rule [Remainder of this page has been left intentionally blank.] 16 Sheng Chen Sheng Chen Fast Horse Technology Limited Sheng Chen Director Sunrise Corporate Holding Ltd. Sheng Chen Director Personal Group Limited Sheng Chen Director Beacon Capital ]
